Kodiak Long Term Debt Total vs Other Liab Analysis
KOD Stock | USD 10.00 0.15 1.48% |
Kodiak Sciences financial indicator trend analysis is infinitely more than just investigating Kodiak Sciences recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Kodiak Sciences is a good investment. Please check the relationship between Kodiak Sciences Long Term Debt Total and its Other Liab accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kodiak Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade Kodiak Stock refer to our How to Trade Kodiak Stock guide.
Long Term Debt Total vs Other Liab
Long Term Debt Total vs Other Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Kodiak Sciences Long Term Debt Total account and Other Liab. At this time, the significance of the direction appears to have strong relationship.
The correlation between Kodiak Sciences' Long Term Debt Total and Other Liab is 0.7. Overlapping area represents the amount of variation of Long Term Debt Total that can explain the historical movement of Other Liab in the same time period over historical financial statements of Kodiak Sciences, assuming nothing else is changed. The correlation between historical values of Kodiak Sciences' Long Term Debt Total and Other Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt Total of Kodiak Sciences are associated (or correlated) with its Other Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Liab has no effect on the direction of Long Term Debt Total i.e., Kodiak Sciences' Long Term Debt Total and Other Liab go up and down completely randomly.
Correlation Coefficient | 0.7 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Long Term Debt Total
Other Liab
Most indicators from Kodiak Sciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Kodiak Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kodiak Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade Kodiak Stock refer to our How to Trade Kodiak Stock guide.At present, Kodiak Sciences' Enterprise Value Over EBITDA is projected to slightly grow based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 0.18, whereas Issuance Of Capital Stock is projected to grow to (263.3 K).
2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 8.7M | 11.0M | 18.3M | 19.2M | Interest Income | 298K | 7.1M | 16.7M | 17.6M |
Kodiak Sciences fundamental ratios Correlations
Click cells to compare fundamentals
Kodiak Sciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Kodiak Sciences fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 358.9M | 1.1B | 904.2M | 666.6M | 479.4M | 492.8M | |
Other Current Liab | 8.7M | 18.0M | 44.4M | 23.5M | 18.4M | 17.0M | |
Total Current Liabilities | 11.7M | 31.4M | 64.7M | 52.5M | 41.7M | 30.0M | |
Total Stockholder Equity | (158.1M) | (291.2M) | (558.2M) | 436.2M | 265.8M | 279.1M | |
Other Liab | 530K | 295K | 100.1M | 100.2M | 115.2M | 120.9M | |
Net Tangible Assets | 345.4M | 860.8M | 663.3M | 436.2M | 501.6M | 358.7M | |
Property Plant And Equipment Net | 2.8M | 78.8M | 108.1M | 115.8M | 175.0M | 183.8M | |
Net Debt | (209.9M) | (867.0M) | (651.5M) | (102.7M) | (203.9M) | (214.1M) | |
Retained Earnings | (158.1M) | (291.2M) | (558.2M) | (892.0M) | (1.2B) | (1.1B) | |
Accounts Payable | 2.6M | 8.6M | 12.4M | 9.1M | 13.6M | 7.1M | |
Cash | 211.8M | 944.4M | 731.5M | 190.4M | 285.5M | 338.7M | |
Non Current Assets Total | 19.6M | 95.3M | 169.4M | 180.6M | 190.1M | 199.6M | |
Non Currrent Assets Other | 5.2M | 10.2M | 55.0M | 58.5M | 8.7M | 8.3M | |
Other Assets | 0.0 | 68.7M | 61.3M | 64.9M | 74.6M | 78.3M | |
Cash And Short Term Investments | 348.2M | 969.0M | 731.5M | 478.9M | 285.5M | 400.5M | |
Common Stock Shares Outstanding | 37.9M | 45.7M | 51.8M | 52.2M | 52.4M | 42.4M | |
Liabilities And Stockholders Equity | (144.6M) | (84.6M) | (317.3M) | 666.6M | 479.4M | 503.3M | |
Non Current Liabilities Total | 1.8M | 175.2M | 176.2M | 178.0M | 171.9M | 112.3M | |
Capital Surpluse | 503.5M | 1.2B | 1.2B | 1.3B | 1.5B | 1.6B | |
Other Current Assets | 2.7M | 6.1M | 6.6M | 7.1M | 3.8M | 4.0M | |
Other Stockholder Equity | (15K) | 1.2B | 1.2B | 1.3B | 1.4B | 1.5B | |
Total Liab | 13.5M | 206.6M | 240.9M | 230.5M | 213.6M | 142.4M | |
Property Plant And Equipment Gross | 2.8M | 78.8M | 111.0M | 122.5M | 197.6M | 207.5M | |
Total Current Assets | 339.2M | 972.0M | 734.8M | 486.0M | 289.3M | 402.0M | |
Accumulated Other Comprehensive Income | 10K | 53K | 0.0 | (1.3M) | (1.5M) | (1.6M) | |
Non Current Liabilities Other | 295K | 175.2M | 176.2M | 178.0M | 100M | 86.8M | |
Property Plant Equipment | 2.8M | 5.1M | 108.1M | 56.4M | 64.8M | 68.1M | |
Net Invested Capital | 345.4M | 860.8M | 663.3M | 436.2M | 265.8M | 408.5M | |
Net Working Capital | 327.5M | 940.6M | 670.1M | 433.5M | 247.6M | 423.9M | |
Retained Earnings Total Equity | (158.1M) | (291.2M) | (558.2M) | (892.0M) | (802.8M) | (762.7M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Kodiak Sciences is a strong investment it is important to analyze Kodiak Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Kodiak Sciences' future performance. For an informed investment choice regarding Kodiak Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kodiak Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade Kodiak Stock refer to our How to Trade Kodiak Stock guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kodiak Sciences. If investors know Kodiak will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kodiak Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.64) | Return On Assets (0.27) | Return On Equity (0.71) |
The market value of Kodiak Sciences is measured differently than its book value, which is the value of Kodiak that is recorded on the company's balance sheet. Investors also form their own opinion of Kodiak Sciences' value that differs from its market value or its book value, called intrinsic value, which is Kodiak Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kodiak Sciences' market value can be influenced by many factors that don't directly affect Kodiak Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kodiak Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kodiak Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kodiak Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.